Search NLS News

Jacob Tolstrup, Executive Vice President, Commercial Operations will leave Lundbeck no later than March 1, 2024. Jacob Tolstrup joined Lundbeck in 1999 and has held various management positions across the company, becoming a member of Lundbeck’s Executive Management team in 2012. “We would like to express gratitude to Jacob for his long-standing commitment to Lundbeck. Jacob has […]

The network, established by Umeå Biotech Incubator, brings together representatives from some 15 companies, focuses on sharing experiences and strategies to deal with the increasingly complex quality requirements facing the industry. The Quality Assurance (QA) role is critical to ensuring product quality and regulatory compliance, and the network actively discusses how to engage employees best […]

InDex Pharmaceuticals will discontinue development of their drug candidate cobitolimod. Thorough analysis of the data from Induction Study 1 of the phase III program CONCLUDE has not provided any results justifying continued development, states the company. “We are very disappointed that we cannot detect a treatment benefit of cobitolimod compared to placebo, and that we […]

Our profile in this issue is professor Mia Phillipson, co-founder of Ilya Pharma, co-director at SciLifeLab, a member of the Royal Swedish Academy of Sciences, and a scientist pioneering immunotherapies. We also have a special report on the life science financial landscape, including VC predictions for 2024, an interview with Thomas Eldered, and a global […]

The board of directors of Kancera has resolved on a new share issue with preferential rights for the company’s existing shareholders of approximately SEK 121.9 million. The objective of the Rights Issue is to secure resources to advance the company’s development program, consisting of the candidate drugs KAND567 and KAND145, to start of new clinical […]

Gunilla Osswald, CEO, BioArctic, has been awarded The Arthur D. Little Nordic Life Science Award 2024. The award is given to people in the Nordics who demonstrate exceptional leadership within the life science industry. Exceptional leadership The jury states that Gunilla Osswald receives the award for exceptional leadership and particularly highlights her ability to create […]

A report jointly published by the AllTrials campaign, Cochrane Denmark, Cochrane Norway, Cochrane Sweden, the Dam Foundation, Melanomföreningen, and TranspariMED, shows that 475 clinical trials involving 83,903 patients completed during 2016-19 in Denmark, Iceland, Finland, Norway and Sweden, have never made their results public in any form. This accounted for 22% of all clinical trial […]

The first human patient implanted with a brain-chip from Neuralink appears to have fully recovered and is able to control a computer mouse using their thoughts, stated Elon Musk late on Monday. “Progress is good, and the patient seems to have made a full recovery, with no ill effects that we are aware of. Patient […]

NEOGAP Therapeutics has been granted a patent in Australia for an innovative method that opens new possibilities in the treatment and diagnosis of multiple sclerosis (MS). The patent strengthens NEOGAP’s strategic intellectual property portfolio and marks an important step in the company’s efforts to develop groundbreaking treatments for autoimmune diseases such as MS, it states. […]

Orion Corporation is evaluating the possible outsourcing of its pharmaceutical production in Kuopio, part of its Global Operations function, to an entity outside Finland. The basis for the possible outsourcing would be the lack of competitiveness of the Kuopio plant and the high investment needs of the plant, states the company. The evaluation is due […]